Summary: From now on, France's Crédit d'Impôt Recherche incentive can cover up to 30% of R&D expenses incurred by innovative French pharma and biotech companies working with us.
We noticed how challenging it is for Executives to find new research partners with world-class expertise while facing financial constraints and adverse fundraising trends.
That is why Experimentica’s CIR accreditation is excellent news to French pharma and biotech companies developing preclinical assets in Ophthalmology. This tax incentive will translate into a significant financial benefit to our customers in France and will allow us to bring our expertise to a broader number of innovative companies.
Reach out to our BD Director Guillaume Demarne for inquiries, by email at firstname.lastname@example.org or by phone at +33 (0) 7 83 55 69 52.